ArticleBMC bioinformatics2025
Aryana-bs: context-aware alignment of bisulfite-sequencing reads.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-metric locality sensitive hashing enhances alignment accuracy of bisulfite sequencing reads: BisHash.Bioinformatics advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDNA methylation is essential in various biological processes, including imprinting, development, inflammation, and numerous disorders, such as cancer. Bisulfite sequencing (BS) serves as the gold standard for measuring DNA methylation at single-base resolution by converting unmethylated cytosines to thymines while leaving methylated cytosines intact. However, this C-to-T conversion presents a well-known challenge in conventional short-read aligners, which treat these conversions as substitutions. Many aligners that require seed sequences fail when frequent C-to-T conversions occur over short distances, resulting in reduced alignment accuracy. To address this challenge, two alignment methods have been well established: three-letter alignment and wildcard alignment. Three-letter alignment faces the significant issue of data loss by converting all thymines to cytosines, which obscures meaningful information. On the other hand, wildcard alignment introduces a biased alignment, failing to treat reads from unmethylated and methylated regions equally, leading to artifacts in methylation level estimation and inaccuracies in quantifying DNA methylation. This work introduces ARYANA-BS, a novel BS aligner that diverges from conventional DNA aligners by directly integrating BS-specific base alterations within its alignment engine. Leveraging known DNA methylation patterns across different genomic contexts, ARYANA-BS constructs five indexes from the reference genome, aligns each read to all indexes, and selects the alignment with the minimum penalty. To further refine alignment accuracy, an optional Expectation-Maximization (EM) step is incorporated, which integrates methylation probability information into the decision-making process for choosing the optimal index for each read. This approach aims to enhance BS read alignment accuracy by accommodating the complexities of DNA methylation patterns across diverse genomic contexts.
resultsExperimental evaluations on both simulated and real data reveal that ARYANA-BS achieves state-of-the-art accuracy, maintaining competitive speed and memory efficiency.
conclusionsARYANA-BS significantly improves alignment accuracy for bisulfite sequencing data by effectively integrating DNA methylation-specific alterations and genomic context. It outperforms existing methods, such as BSMAP, bwa-meth, Bismark, BSBolt, and abismal, particularly in robustness against genomic biases and alignment of longer, higher-error reads, demonstrating suitability for cancer research and cell-free DNA studies. While the Expectation-Maximization (EM) algorithm provides only modest initial improvements, it establishes a valuable framework for future refinement and potential enhancements in sensitive applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.